|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/277 | |
| A61K 31/198 | |||
| A61K 45/06 | |||
| A61P 25/16 | |||
| A61K 9/20 | |||
| A61K 9/28 |
| (11) | Number of the document | 2542220 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11709446.6 |
| Date of filing the European patent application | 2011-03-03 | |
| (97) | Date of publication of the European application | 2013-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/FI2011/000013 |
| Date | 2011-03-03 |
| (87) | Number | WO 2011/107653 |
| Date | 2011-09-09 |
| (30) | Number | Date | Country code |
| 438416 P | 2011-02-01 | US | |
| 412821 P | 2010-11-12 | US | |
| 310398 P | 2010-03-04 | US |
| (72) |
ROURU, Juha, FI
KUOPPAMÄKI, Mikko, FI
ELLMEN, Juha, FI
MÄNNISTÖ, Pekka, FI
|
| (73) |
Orion Corporation,
Orionintie 1, 02200 Espoo,
FI
|
| (54) | USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON`S DISEASE |
| USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON`S DISEASE |